Substance
ID:341948
Names and Identifiers
Synonyms
Hydroxylammonium chloride盐酸羟胺Hydroxylamine hydrochloride羟胺 盐酸盐
IUPAC Traditional name
hydroxylamine hydrochloride
IUPAC name
hydroxylamine hydrochloride
Registration numbers
CAS Number
EC Number
MDL Number
Beilstein Number
PubChem SID
Properties
Product Information
Purity
99.999% trace metals basis
Impurities
≤0.005% S compounds
≤0.25 meq/g Titr. free acid
<10 ppm total metallic impurities
Linear Formula
NH2OH · HCl
Ignition Residue
≤0.05%
Cation Traces
heavy metals: ≤5 ppm
Fe: ≤5 ppm
NH4+:, passes test
Safety Information
European Hazard Symbols
Harmful (Xn)
Nature polluting (N)
Explosive (E)MSDS Link
German water hazard class
3
GHS Pictograms
Corrosive to metals, category 1
Skin corrosion, categories 1A,1B,1C
Serious eye damage, category 1
Hazardous to the aquatic environment
Acute hazard, category1
Chronic hazard, categories 1,2
Acute toxicity (oral, dermal, inhalation), category 4
Skin irritation, category 2
Eye irritation, category 2
Skin sensitisation, category 1
Specific Target Organ Toxicity – Single exposure, category 3
Respiratory sensitization, category 1
Germ cell mutagenicity, categories 1A,1B,2
Carcinogenicity, categories 1A,1B,2
Reproductive toxicity, categories 1A,1B,2
Specific Target Organ Toxicity – Single exposure, categories 1,2
Specific Target Organ Toxicity – Repeated exposure, categories 1,2
Aspiration Hazard, category 1
Safety Statements
36/37-61
Packing Group
2
GHS Signal Word
Warning
RID/ADR
UN 2923 8/PG 2
Hazard Class
8
UN Number
2923
GHS Hazard statements
H290-H302-H312-H315-H317-H319-H351-H373-H400
Personal Protective Equipment
Eyeshields, Faceshields, full-face particle respirator type N100 (US), Gloves, respirator cartridge type N100 (US), type P1 (EN143) respirator filter, type P3 (EN 143) respirator cartridges
GHS Precautionary statements
P273-P280-P305+P351+P338
Risk Statements
2-21/22-36/38-40-43-48/22-50
RTECS
NC3675000
Physical Property
Melting Point
155-157 °C (dec.)(lit.)
Density
1.67 g/mL at 25 °C(lit.)
Molecule Details
Biochem/physiol Actions
MAO inhibitor; inhibits platelet aggregation.
Features and Benefits
Meets A.C.S. reagent specifications.
Packaging
50, 250 g in poly bottle
Application
Reactant for preparation of:
• Organosilane amines as potent inhibitors and structural probes of influenza A virus M2 proton channel1
• Lamellarin D analogues as inibitors of topoisomerase I and potential antitumor agents2
• Azapeptide tocolytic agents as inhibitors of prostaglandin F2a receptor for preventing preterm labor3
• Thiazolidinones spiro-fused to indolin-2-ones as potent and selective inhibitors of Mycobacterium tuberculosis protein tyrosine phosphatase B4
• Orally bioavailable quinoline-based antidiabetic dipeptidyl peptidase IV inhibitors targeting Lys5545
• Pyrimidine nucleoside derivatives with nitric oxide donors as antiviral agents6
• Benzyladenosine compounds targeting adenosine A2A receptor and adenosine transporter for neuroprotection7
• Naphthol derivatives as inhibitors of the vanilloid receptor TRPV1 with improved potency in rat cystometry models of urinary incontinence8
MAO inhibitor; inhibits platelet aggregation.
Features and Benefits
Meets A.C.S. reagent specifications.
Packaging
50, 250 g in poly bottle
Application
Reactant for preparation of:
• Organosilane amines as potent inhibitors and structural probes of influenza A virus M2 proton channel1
• Lamellarin D analogues as inibitors of topoisomerase I and potential antitumor agents2
• Azapeptide tocolytic agents as inhibitors of prostaglandin F2a receptor for preventing preterm labor3
• Thiazolidinones spiro-fused to indolin-2-ones as potent and selective inhibitors of Mycobacterium tuberculosis protein tyrosine phosphatase B4
• Orally bioavailable quinoline-based antidiabetic dipeptidyl peptidase IV inhibitors targeting Lys5545
• Pyrimidine nucleoside derivatives with nitric oxide donors as antiviral agents6
• Benzyladenosine compounds targeting adenosine A2A receptor and adenosine transporter for neuroprotection7
• Naphthol derivatives as inhibitors of the vanilloid receptor TRPV1 with improved potency in rat cystometry models of urinary incontinence8
Molecular Spectra
No Data Available
Click here to submit data
References
No Data Available
Click here to submit data